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In recent years, intellectual property in medicine has generated much debate, becoming
one of the most significant issues in modern day medical ethics and linking in with wider
discussions about the commercialisation of medicine and the commodification of the
human body. Recent high-profile cases in the USA have centred on gene patenting,
that having been enthusiastically practised by universities and biotechnology companies,
is now having its legality questioned. The unexpected March 2010 ruling of a federal
court against Myriad Genetics, which invalidated the company’s patents on the
BRCA1 and BRCA2 genes, has highlighted the complexities that now govern the ethical
and legal tenure of asserting property rights over biological material.
1
These events provide an ideal opportunity for historians of medicine to strengthen
their engagement with what we recognise today as ‘intellectual property’.
2 While histor-
ians of science and technology have produced a wealth of literature on the subject,
3
medical ideas and procedures, understood in a more clinical sense, require further disen-
tangling from this broader scope, not least because, as I intend to show here, medical
practitioners’ experiences of intellectual property can be so vastly different from that
of other professions.
Such concerns have realised themselves in my own work looking at developments in
British surgery in the nineteenth century, a period during which there was heightened
interest in the social role of the inventor. Christine MacLeod has identified a growing
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1For an overview of the case and March 2010
ruling see: Bob Carlson, ‘Surprise District Court
Ruling Invalidates Myriad Genetics’ BRCA Patents,
But Appeal is Pending’, Biotechnology Healthcare,
7, 2 (2010), 8–9.
2The term ‘intellectual property’ is relatively
novel, not emerging as part of regular legal
vernacular until the end of the nineteenth century.
However, it is used here to broadly encompass a
range of issues surrounding the ownership of
intellectual labours, from patenting to trade marking,
to non-legal methods of managing and recognising
credit such as publication, peer recognition and
pecuniary reward. The term ‘intellectual property’ is
arguably anachronistic for historians working on
periods before the twentieth century, but nonetheless,
for the purposes of this paper, it expresses many of
the facets of knowledge ownership.
3This is captured most recently in the work of
Peter Galison, Mario Biagioli, Christine MacLeod
and Graeme Gooday.
319cult of heroism around inventors in the eighteenth and early nineteenth century, centred
on figures such as Isambard Kingdom Brunel, George Stephenson and James Watt, and
the highly visible and influential products of their labours. The impoverished inventor
became the heroic Briton, heralded for making an important contribution to national
industry.
4 From the 1850s, major discussion ensued as to the extent to which inventor’s
rights should be legally enshrined, and numerous legislative changes over the next thirty
years resulted in patent laws which served to strengthen patentee rights.
5
Medical practitioners were notably absent from these debates. While some commenta-
tors hinted toward dissatisfaction with the lack of protection or reward for intellectual
labours in medicine,
6 discussions of inventor’s rights in the media rarely referenced med-
icine and the profession appeared reluctant to open itself up to the debate. When patent-
ing was discussed within the pages of the medical journals, it tended to be with suspicion
and disdain. For many, there was discordance between property rights and medicine, an
inherent contradiction in permitting excessive individual reward within the framework of
altruism which increasingly bound orthodox medical culture together. Scottish physician
William Gairdner claimed to voice the view of many in 1868, stating his belief that
there was:
A principle now firmly established in the medical profession... that the status of its members is
considered lowered by any attempt to establish property in any remedy, or other invention for
the relief of disease; whether by concealment, or by patenting, or otherwise advertising the inven-
tion for the benefit of its presumed owner.
7
Much of the focus was on the popularity of so-called ‘patent medicines’ – patented or
trademarked drugs, often luridly advertised, which grew in popularity in Britain towards
the end of the century
8 - but interwoven within the anti-patenting sentiment was a moral
bent which implied that careful negotiation was needed when attempting to establish
ownership around an invention or innovation, even if it didn’t involve patenting. For,
regardless of the moral stance, credit disputes arose frequently and publicly in medicine.
In the next section, the controversial operation of ovariotomy is presented as a short case
study of the complexities that could emerge during these negotiations.
Thomas Spencer Wells and Charles Clay
By the 1860s, those who performed ovariotomy – the premise of which at that time
was predominantly to remove cystic ovaries via an abdominal incision – were begin-
ning to overcome much of the opposition they had faced over the past two decades.
4Christine MacLeod, Heroes of Invention:
Technology, Liberalism and British Identity,
1750–1914 (Cambridge: Cambridge University Press,
2007), 2.
5Fritz Machlup and Edith Penrose, ‘The Patent
Controversy in the Nineteenth Century’ Journal of
Economic History, 10, 1 (1950), 1–29: 28–9.
6For examples of literature arguing for greater
reward for intellectual labours in medicine, see James
A. Dorr, ‘Are Improvements in Medicine and Surgery
Proper Subjects of Patents?’, The Lancet, 49, 1237
(1847), 523–4 and Anon., Edinburgh Review, 136,
278 (1872), 488–515: 514–15.
7Anon., ‘The Theory of Professional
Remuneration’, British Medical Journal, 1, 371
(1868), 122–3.
8T.A.B Corley: ‘Interactions Between the British
and American Patent Medicine Industries,
1708–1914’, pamphlet reprint from Business and
Economic History, 16 (1987), 111–29: 112.
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able light and by the mid-century the procedure was being proclaimed by many as
symbolic of the future of modern surgery, a bright new hope in the exploration
and treatment of diseased organs, both of the female reproductive system and more
generally of the abdomen. Its success gave heightened credibility to those who had
continued to persevere with the operation, and discussion soon began to shift from
the propriety of its performance to the question of who had been responsible for its
progress.
One of the longest and most controversial disputes to arise was that between London
surgeon Thomas Spencer Wells and Manchester surgeon Charles Clay. Wells was one of
the best known surgeons of the Victorian era. After his first successful ovariotomy in
1858, he had begun performing it consistently and had built up a distinguished reputation
through his work on the operation that allowed him to retain a lucrative private practice
as well as his position at the Samaritan Hospital for Women. In 1865 he published Dis-
eases of the Ovaries: Their Diagnosis and Treatment. The book contained detailed infor-
mation on all Wells’ ovariotomy cases and was widely praised for being the first
complete record of a surgeon’s experience with the operation, detailing both successes
and failures.
What is most significant about the book from the perspective of intellectual property
however, is the introduction. It was here that Wells discreetly compartmentalised his
own work in ovarian surgery from that which had come before, and where he implied
that it was he who had prevented the operation from sliding into disuse in the 1850s.
It was an easy narrative for Wells to construct - the operation’s progress had been piece-
meal and marred with prominent opposition - but, as a number of surgeons would pub-
licly claim,
9 it also painted an inaccurate picture that what had come before Wells had
had little impact and that ovariotomy was so opposed that it would have been given up
on altogether if he had not revived it.
In one respect in particular, his version of ovariotomy’s history attracted attention: his
failure to acknowledge Charles Clay. Clay differed from many other self-proclaimed
ovariotomists at that point; rather than making sporadic attempts at the operation, he
had been performing it consistently since 1842, preceding Wells’ first success by
some sixteen years. Clay was highly respected, both in Britain and abroad,
10 and was
believed by many to have been the first to have successfully performed the operation
in England.
11 By the time of the publication of Wells’ book, both claimed a similar
9One example is Birmingham surgeon Robert
Lawson Tait who was adamant that Wells had stolen
credit from earlier ovariotomists. See Lawson Tait,
‘The Revival of Ovariotomy’, British Medical
Journal, 2, 1249 (1884), 1165.
10Clay was well respected by American
ovariotomists. See Edmund Peaslee’s defence of
Clay’s legacy in: Edmund Randolph Peaslee, Ovarian
Tumors: Their Pathology, Diagnosis and Treatment,
Especially by Ovariotomy (New York: D. Appleton,
1872), 272
11During the 1830s a number of provincial
practitioners, such as William West and William
Jeaffreson, began to remove diseased ovaries through
small abdominal incisions; however the status of
these operations as ‘ovariotomies’ was disputed by
Clay, due to the lack of major abdominal section.
Some ascribed the first successful ovariotomy in
Britain to Scottish surgeon John Lizars who had
removed a diseased ovary in 1825. Clay
acknowledged Lizars and credited himself only as the
first to have performed ovariotomy in England. See
Charles Clay, ‘Dr. Clay’s Reply to Dr. Granville on
Ovarian Extirpation’, Medical Times, 8, 204 (1843),
326–7.
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12 Yet, in his intro-
duction, Wells denounced Clay’s work, claiming that ‘his operations not being per-
formed in an hospital before numerous professional witnesses and no connected series
of cases being published, his example had but little influence.’
13
Wells’ dismissal of Clay was indicative of what was increasingly required of medical
men to affirm their authority in a credit claim and, whether intentionally or not, had
drawn attention to the old fashioned practices of Clay who continued to operate mainly
outside the more public space of the hospital – unlike Wells, who used his position at
the Samaritan Hospital to attract many eminent witnesses to his operations. Public
operations were essential in the construction of a surgeon’s reputation, and operations
performed in private practices, whether witnessed or not, were demoted in value in a
medical culture that increasingly viewed the hospital as the centre of innovation and
education. Wells’ comment on the necessity of adequate publication may have seemed
a more obvious requirement to practitioners wishing to make public their innovation,
but the criticism rankled with Clay, in particular the implication that he should have
produced a monograph rather than have published separate articles. Clay disagreed
with the idea that such a publication was necessary to ensure credit, believing that
books were ‘too often only a polite advertisement of the author’s whereabouts’.
14
Monographs certainly did have the capacity to function in this way but Clay had failed
to acknowledge their growing importance as a way of stabilising credit, and their part
in fashioning surgeons into gentlemen and scientists who could compete with physi-
cians in their eloquence. Text was being ma d ee q u a lt oo p e r a t i n ga sa ne x p r e s s i o no f
surgical authorship.
Clay was sufficiently provoked by this perceived assault on his reputation to send
a series of letters to The Lancet in 1865 after the publication of Wells’ book, and
then a second set to the British Medical Journal in 1880 in the midst of celebrations
of Wells’ thousandth ovariotomy. In both sets of correspondence he presented a model
of credit that differentiated greatly from that of Wells. For Wells the value of credit
was related to the acceptance and approval that the operation received from the pro-
fession. Credit was not simply a matter of priority – the first to successfully extirpate
a diseased ovary in this case – but derived from winning the trust of other medical
men. Without this trust, which Wells did not believe existed, Clay’s credit could be
challenged and even negated by competitors. Clay, on the other hand, reiterated the
value of priority. He evoked the image of himself as an isolated inventor, working
before professional approval had glorified the operation. He had been the one to
demonstrate the operation was workable, alone and unsupported. In 1880, fifteen
years after the publication of Wells’ book and nearing his eightieth year, Clay
remained as indignant as ever that credit had been stolen from him: ‘my operations
12During their exchange of letters in The Lancet
during 1865, Wells and Clay quibbled a great deal
over the minutiae of their disclosed statistics – for
instance, whether incomplete or slightly different
operations should be included or not – however, both
admitted broadly similar success rates.
13T. Spencer Wells, Diseases of the Ovaries:
Their Diagnosis and Treatment: Vol. 1 (London:
John Churchill & Sons, 1865), x.
14Charles Clay, ‘On Ovariotomy and
Ovariotomists’, The Lancet, 85, 2165 (1865), 200–2:
201.
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m e ,i nm yd i f f i c u l tt a s k . ’
15
The dispute showed that credit in operative surgery could be particularly slippery. Imi-
tation of practice was an established tenet of surgical education – for a surgeon to witness
another’s operations and then apply what he saw to his own work was fundamental to
the transmission of knowledge.
16 But any idea for a surgical method had to be suitably
adjusted to the variability of the case and the idiosyncrasies of the surgeon, making defi-
nitive statements about where methods of practice originated difficult to maintain. Clay
himself appeared unsure at times of how Wells’ method of operating related to his
own. In one letter to The Lancet he described Wells and himself as employing ‘two modes
of practice... perfectly distinct from and opposed to each other’ and yet in the same letter
alluded to Wells as his imitator.
17 The statements were inconsistent, encouraging readers
to see both sameness and difference in their operations, but Clay used both tactics to
assert that he was the original pioneer of ovariotomy.
Maintaining personal identity in an operation – away from one’s own practice of it – was
not always easy, and the blurred boundaries of imitation and originality in operations
presented a challenge to the management of credit. Yet it was important that the credit
issue was dealt with, not just for the sake of individuals involved in disputes. For ovariot-
omy, conceptualised as a new operation with little history before the nineteenth century,
18
historicising the operation and establishing its origins was also important for collective
identity. It allowed for the construction of a positive narrative to the operation that reflected
the growing confidence of the surgical self.
Operative surgery is useful for positing historical questions about intellectual property
in medicine away from the usual patented product foci. In the case of ovariotomy, we see
that lack of patent protection meant other ways had to be found to construct definitive
categories of who invented what and when. Surgeon’s individualised methods and abil-
ities and the variability in the cases they were faced with had the potential to destabilise
collective assumptions of what constituted a specific type of operation. The continued
ambiguity that surrounds the intellectual property of innovations not embodied in physi-
cal products
19 is perhaps demonstrative of the particular difficulties there can be in
applying ownership to methods.
Framing medical history in the context of knowledge ownership is worthy of both
reassessment and extension. The role of the patient’s body in the establishment of credit,
for example, has barely been considered, even though case histories and pathological
15Charles Clay ‘The History of Ovariotomy’,
British Medical Journal, 2, 1020 (1880), 109–10: 110.
16Thomas Schlich has discussed in detail the
application of tacit knowledge to surgery. See
Thomas Schlich, Surgery, Science and Industry:
A Revolution in Fracture Care, 1950s–1990s
(Basingstoke: Palgrave Macmillan, 2002), 65–85.
17Charles Clay, ‘The Ovariotomy Controversy’,
The Lancet, 85, 2171 (1865), 380.
18Wells, op. cit. (note 13), xiii.
19In UK law, methods – for example, a business
or medical diagnostic method – are unpatentable. In
the USA, the case of Bilski vs Kappos (2010) has
highlighted the current ambiguities regarding the
patentability of methods. The case saw the Supreme
Court reject the principle that patentability could
only be determined by the ‘machine or
transformation test’ – i.e., that a process has to be
tied to a particular machine, or involve the
transformation of an article into a different state –
potentially paving the way for a system in which
there will be more patent protection for non-material
innovations.
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priority disputes are not insignificant asides; they are often the visible signs of flows of
power over which control is sought but not always found.
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